Year: 2015

FCPA procedures, internal controls and travel, entertainment and gifts were at the center of the SEC’s latest FCPA action. The action names as a Respondent Bristol-Myers Squibb Company and focuses on its efforts to sell pharmaceuticals in China. In the …

SEC, Bristol-Myers Settle FCPA Charges Read More »

Tagged with: , ,